Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;27(33):5583-5598.
doi: 10.2174/0929867326666190731141055.

Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors

Ying Xiong  1 , Mingming Zhang  2 , Yingxia Li  2
Affiliations
Review

Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors

Ying Xiong et al. Curr Med Chem. 2020.

Abstract

CBP and p300 are two closely related Histone Acetyltransferases (HATs) that interact with numerous transcription factors and act to increase the expression of their target genes. Both proteins contain a bromodomain flanking the HAT catalytic domain that is important in binding of CBP/p300 to chromatin, which offers an opportunity to develop protein-protein interaction inhibitors. Since their discovery in 2006, CBP/p300 bromodomains have attracted much interest as promising new epigenetic targets for diverse human diseases, including inflammation, cancer, autoimmune disorders, and cardiovascular disease. Herein, we present a comprehensive review of the structure, function, and inhibitors of CBP/p300 bromodomains developed in the last several years, which is expected to be beneficial to relevant studies.

Keywords: CBP/p300; bromodomain; drug discovery; genes; histone acetyltransferases; inhibitors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

LinkOut - more resources